Correlation Between Analog Devices and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Analog Devices and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Analog Devices and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Analog Devices and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Analog Devices and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Analog Devices with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Analog Devices and Centessa Pharmaceuticals.
Diversification Opportunities for Analog Devices and Centessa Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Analog and Centessa is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Analog Devices and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Analog Devices is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Analog Devices are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Analog Devices i.e., Analog Devices and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Analog Devices and Centessa Pharmaceuticals
Considering the 90-day investment horizon Analog Devices is expected to under-perform the Centessa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Analog Devices is 1.89 times less risky than Centessa Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 1,567 in Centessa Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of 224.00 from holding Centessa Pharmaceuticals PLC or generate 14.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Analog Devices vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Analog Devices |
| Centessa Pharmaceuticals |
Analog Devices and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Analog Devices and Centessa Pharmaceuticals
The main advantage of trading using opposite Analog Devices and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Analog Devices position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Analog Devices vs. NXP Semiconductors NV | Analog Devices vs. Qualcomm Incorporated | Analog Devices vs. Broadcom | Analog Devices vs. Microchip Technology |
| Centessa Pharmaceuticals vs. Tff Pharmaceuticals | Centessa Pharmaceuticals vs. Eliem Therapeutics | Centessa Pharmaceuticals vs. Inhibrx | Centessa Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |